| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.6M | -15.3% |
| R&D Expense | $149.4M | +52.2% |
| SG&A Expense | $52.2M | +27.6% |
| Operating Income | -$160.0M | -77.9% |
| Pre-tax Income | -$130.2M | -95.6% |
| Income Tax | $959K | +301.3% |
| Net Income | -$131.2M | -96.4% |
| EPS (Basic) | -$2.92 | -68.8% |
| EPS (Diluted) | -$2.92 | -68.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.7M | -38.8% |
| Short-term Investments | $142.5M | -15.7% |
| Accounts Receivable | $4.1M | +138.7% |
| Current Assets | $306.4M | -27.8% |
| Total Assets | $376.5M | -17.5% |
| Current Liabilities | $78.9M | +9.8% |
| Total Liabilities | $129.5M | -7.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$149.9M | -151.4% |
| Capital Expenditures | $7.6M | +772.1% |
| Investing Cash Flow | $2.8M | +101.9% |
| Financing Cash Flow | $58.7M | -79.2% |
| Free Cash Flow | -$157.5M | -160.3% |
| Stockholders' Equity |
| $247.1M |
| -21.9% |